Article Text

PDF

233 Anti-arrhythmic role of sphingosine 1-phospahte in post-operative atrial fibrillation by pak1 activation
  1. Naseer Ahmed1,
  2. Daniele Linardi1,
  3. Sajeela Ahmed2,
  4. Riffat Mehboob2,
  5. Giovanni Battista Luciani1,
  6. Giuseppe Faggian1,
  7. Alessio Rungatscher1
  1. 1University of Verona, Division of Cardiac Surgery
  2. 2King Edward Medical University, Biomedical Sciences

Abstract

Background Atrial Fibrillation (AF) is the most common arrhythmia occurring post cardiac surgery. The incidence varies and depends on the type of surgery. Postoperative AF may cause hemodynamically unstable, that increase the risk of stroke and increase mortality. Current management for prophylaxis of postoperative AF is not satisfactory.

Objectives The purpose of this study is to investigate the anti-arrhythmic role of sphingosine 1-phosphate to prevent post-cardiac surgery AF.

Methods Sprague-Dawley Rats (300-350grams) Obtained from Harlan Laboratories (Udine, Italy). They were fed standard rat chow, which they had access to ad libitum. Randomly categorised into two groups n=10 each group. One group was treated with sphingosine 1-phospahte receptor agonist fingolimod (1 mg/kg, i.v) and the control group was treated with saline. Following 15 min of treatment, cardioplegic arrest with the support of cardiopulmonary bypass. ECG electrodes were attached to limbs and using power lab charts ECG monitored and analysed. Following monitoring of rhythm for 24 hours, all animals were sacrificed and myocardial tissue was collected to analyse Pak1 protein.

Results The administration of fingolimod led to significantly better and fast recovery as compared to the control group. The episodes of AF recorded during 24 hours in the treated group was low versus the control group (p0.001). We also investigated Pak1 protein by western blot and immunohistochemistry. Expression of Pak1 observed higher in the fingolimod-treated group(p0.05).

Conclusion Sphingosine 1-phosphate receptor agonist fingolimod plays important role in prevention of AF-related to cardiac surgery by activating the Pak1 pathway.Fingolimod is FDA-approved sphingolipid that can be the potential therapeutic drug for post-operative AF prophylaxis.

  • Fingolimod
  • Cardiac Surgery
  • Atrial Fibrillation

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.